Primary Care/Hospitalist
RSSArticles
-
Lifitegrast Ophthalmic Solution (Xiidra)
Lifitegrast is approved for the treatment of the signs and symptoms of dry eye disease.
-
Which Patients with TIA Are at High Risk for Recurrent Cerebral Vascular Events?
The objective of this study was to determine predictors of early recurrent cerebral vascular events among patients with transient ischemic attacks or minor stroke.
-
Predictive Accuracy of the New Risk Equation
In a large real-world population, the Pooled Cohort Risk Equation substantially overestimated five-year risk of cardiovascular events in adults without diabetes.
-
Improving Blood Pressure Through Enhanced Sleep
The use of a benzodiazepine hypnotic among hypertensive patients was associated with improvements in both sleep scores and blood pressure.
-
U.S. Preventive Services Task Force Recommends Against Genital Herpes Screening
The CDC estimates that about one in six U.S. residents ages 14-49 has genital herpes.1 In new draft guidance, the U.S. Preventive Services Task Force (USPSTF) recommends against using current blood tests to screen for genital herpes in people with no signs or symptoms of infection, including adolescents and adults, as well as pregnant women.2
-
The Trajectories of Vasomotor Symptoms Eyed Across the Menopausal Transition
Most women will get hot flashes or night sweats at some point during menopause. Research indicates 42% to 79% of women experience vasomotor symptoms (VMSs) during the menopausal transition.1-4 Just-published findings show that women fit into four distinct groups when it comes to having hot flashes and night sweats, which offers potential ramifications for therapy and prevention of future health conditions, according to research led by the Graduate School of Public Health at the University of Pittsburgh.5
-
Counsel on Convenience and Effectiveness Of Immediate Postpartum LARC
Unplanned pregnancies can happen in the postpartum period. Data indicate 40-57% of women report having unprotected intercourse before the routine six-week postpartum visit.1,2 The American College of Obstetricians and Gynecologists (ACOG) has just issued a new committee opinion on the use of long-acting reversible contraception (LARC) in the postpartum period to help stem such pregnancies.3
-
Combined Hormonal Contraception and Migraine — Add Clinical Information to Your Practice
What do you know when it comes to prescribing combined hormonal methods for women with migraines? A new two-part Association of Reproductive Health Professionals webinar series, “Migraines & the Female Patient,” offers information on the epidemiology of migraines and how to counsel affected women on their contraceptive options.
-
Get the Latest Guidance on Zika Virus In the Family Planning Setting
Clinicians can get up to speed on the latest strategies for Zika virus prevention, as well as implement the latest guidance surrounding Zika in the family planning setting, with new webinars hosted by the American College of Obstetricians and Gynecologists (ACOG) and the CDC.
-
Updates Issued for US MEC, SPR — What Do the Changes Mean?
Time to update your practice. The U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (US MEC 2016) and the U.S. Selected Practice Recommendations for Contraceptive Use, 2016 (US SPR 2016) have new information.1,2